Forecast: Trachea, Bronchus or Lung Malignant Neoplasms Mortality in Germany

In Germany, the forecast indicates a gradual decline in male mortality due to trachea, bronchus, or lung malignant neoplasms from 26.22 thousand in 2024 to 24.82 thousand by 2028. This trend reveals an average annual decrease of approximately 1% over this period, indicating ongoing improvements in healthcare interventions and possible lifestyle changes.

Future trends to watch for include advancements in early detection and treatment technologies, as well as potential shifts in public health policies and smoking cessation programs that could further accelerate the reduction in mortality rates. Ongoing research into targeted therapies may also contribute to improved outcomes.